Key points from article :
The AI-biology company GenBio has outlined an ambitious plan to use artificial intelligence to model biology at increasingly complex levels, with the eventual goal of creating a digital representation of an entire organism. The three-stage blueprint aims to move beyond AI models that study individual biological components towards systems capable of simulating how those components interact.
The idea is to build a connected hierarchy of biological models, progressing from relatively simple systems towards increasingly sophisticated simulations of cells, tissues and ultimately whole organisms. Such a system could allow researchers to explore how changes at one level of biology affect others, potentially providing a powerful new way to investigate disease and test possible treatments.
GenBio's vision reflects a broader shift in biotechnology, where AI is being used not simply to analyse biological data but to model and predict biological behaviour. If successful, a sufficiently detailed "digital organism" could allow scientists to run virtual experiments before testing their ideas in living systems, potentially speeding up drug discovery and reducing the number of costly laboratory experiments.
The concept remains highly ambitious, however, and modelling the extraordinary complexity of living organisms is a significant scientific challenge. GenBio's proposal is therefore less a finished technology than a roadmap for connecting increasingly capable biological AI models into a unified simulation of life.
